ECARX Signs MoU with Arm to advance next-generation high-performance AI computing across industry applications

MoU establishes framework to explore advanced solution development, including joint R&D and…

InventisBio Announces Topline Results of a Phase III Study of Nomelcitinib (TYK2 Inhibitor), Demonstrating Promising Efficacy and Safety in Patients with Moderate to Severe Plaque Psoriasis.

SHANGHAI, Nov. 2, 2026 /PRNewswire/ — InventisBio Co., Ltd. today announced that…

LianLian Global and Cobre Collaborate to Streamline China-Latin America Payments

HONG KONG, Nov. 2, 2026 /PRNewswire/ — LianLian Global, the cross-border payment…

FREELANDER Deepens Its Middle East Roll-out and Makes Morocco Its First Step into Africa

Full-scale entry into the Middle East is set for the first half…

Xinhua Silk Road: 2026 International Exchange on Women and Children's Health held in Boao, Hainan

BEIJING, Nov. 2, 2026 /PRNewswire/ — The 2026 International Exchange on Women…

Trade Your View Before the IPO: Vantage Spotlights its Pre-IPO CFD Offering

Vantage highlights how eligible clients can express long or short views before…

Sharon AI to Announce Third Quarter 2026 Results

NEW YORK, Nov. 2, 2026 /PRNewswire/ — SharonAI Holdings Inc. (NASDAQ: SHAZ)…

Global Smart Toilet Sales Leader JOMOO Enters Japan, Expanding Its International Footprint

JOMOO opens its first Tokyo showroom, bringing globally recognized design and smart…